Wistar scientists identify novel therapeutic approach to re-activate immune response against tumors – BIOENGINEER.ORG

PHILADELPHIA – (June 21, 2022) – Due to the development of resistance to chemotherapy and recurrent tumors, patients with ovarian cancer often have low survival rates. Therefore, new therapeutic options such as targeted therapy that boosts antitumor immunity are needed to improve ovarian cancer treatment efficacy and patient survival. PHILADELPHIA – (June 21, 2022) – … Read more